XML 48 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Tax (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Tables  
Schedule of Components of Income Tax Expense

The components of income tax expense (benefit) attributable to continuing operations are as follows:


 

 

Years ended December 31,

 

 

 

2017

 

 

2016

 

 

 

 

 

 

 

 

Current expense:

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

 

 

 

 

Foreign

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred expense (benefit):

 

 

 

 

 

 

 

 

Federal

 

$

(762,580

)

 

$

 

State

 

 

(46,960

)

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

(809,540

)

 

$

 

Schedule of Income Tax Rate Reconciliation

The differences between the Company’s consolidated income tax expense attributable to continuing operations and the expense computed at the 34% United States statutory income tax rate were as follows:


 

 

Years ended December 31,

 

 

 

2017

 

 

2016

 

 

 

 

 

 

 

 

Federal income tax expense at statutory rate

 

$

(4,495,000

)

 

$

(4,411,000

)

Increase (reduction) in income tax resulting from:

 

 

 

 

 

 

 

 

State and local income taxes, net of federal benefit

 

 

(194,000

)

 

 

69,000

 

Foreign rate differential

 

 

16,000

 

 

 

(18,000

)

Non-deductible expenses

 

 

9,000

 

 

 

8,000

 

Prior-period true-up

 

 

 

 

 

547,000

 

Research & development credit

 

 

(409,000

)

 

 

(575,000

)

Stock-based compensation

 

 

84,000

 

 

 

113,000

 

Acquisition costs

 

 

96,000

 

 

 

 

Reserve for loss carryforwards limited by Sec. 382

 

 

(541,000

)

 

 

 

Tax reform impact

 

 

8,024,000

 

 

 

 

Other

 

 

45,460

 

 

 

(1,000

)

Increase in valuation allowance

 

 

(3,445,000

)

 

 

4,268,000

 

 

 

$

(809,540

)

 

$

 

Schedule of Deferred Tax Assets and Liabilities

The tax effects of temporary differences and operating loss carryforwards that gave rise to significant portions of the deferred tax assets and deferred tax liabilities were as follows at December 31, 2017 and December 31, 2016:


 

 

December 31,

 

 

 

2017

 

 

2016

 

 

 

 

 

 

 

  

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforward

 

$

15,117,487

 

 

$

19,303,020

 

Research & development credit

 

 

1,966,964

 

 

 

1,557,475

 

Stock-based compensation

 

 

629,447

 

 

 

838,297

 

Contingent consideration

 

 

599,343

 

 

 

 

Other

 

 

128,522

 

 

 

203,661

 

Deferred tax assets

 

 

18,441,763

 

 

 

21,902,453

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Property, plant and equipment, primarily due to differences in depreciation

 

 

(26,307

)

 

 

(41,953

)

Intangible assets

 

 

(1,302,220

)

 

 

 

Deferred tax liabilities:

 

 

(1,328,527

)

 

 

(41,953

)

 

 

 

 

 

 

 

 

 

Valuation allowance

 

 

(18,415,456

)

 

 

(21,860,500

)

Net deferred income taxes

 

$

1,302,220

 

 

$